GTCDxᵀᴹ Mouse Anti-AAV8 antibody ELISA Kit
Regulatory status: For research use only, not for use in diagnostic procedures.
COA
Sample
Serum
Species Reactivity
Mouse
Intended Use
The Mouse anti-AAV8 ELISA is used as an analytical tool for qualitative determination of antibodies to AAV8 in Mouse serum.
Contents of Kit
| No. | Components | Size | Storage Conditions |
| 1 | AAV8 Capsid Coated Microtiter Plate | 12×8 wells | 2-8°C |
| 2 | Negative Control, ready to use | 1 × 1 ml | 2-8°C |
| 3 | Mouse Anti-AAV8 Positive Control, ready to use | 1 × 1 ml | 2-8°C |
| 4 | Anti-mouse IgG Conjugate, ready to use | 1 × 12 ml | 2-8°C |
| 5 | Sample Diluent, ready to use | 1 × 50 ml | 2-8°C |
| 6 | Wash Buffer, 20 × concentrate | 1 × 50 ml | 2-8°C |
| 7 | TMB Substrate, ready to use | 2 × 6 ml | 2-8°C |
| 8 | Stop Solution, ready to use | 1 × 7 ml | 2-8°C |
| 9 | Instruction Manual | 1 |
Storage
1. All reagents should be stored at 2°C to 8°C for stability.
2. All the reagents and wash solutions should be used within 12 months from manufacturing date.
3. Before using, bring all components to room temperature (18-25°C). Upon assay completion ensure all components of the kit are returned to appropriate storage conditions.
4. The Substrate is light-sensitive and should be protected from direct sunlight or UV sources.
2. All the reagents and wash solutions should be used within 12 months from manufacturing date.
3. Before using, bring all components to room temperature (18-25°C). Upon assay completion ensure all components of the kit are returned to appropriate storage conditions.
4. The Substrate is light-sensitive and should be protected from direct sunlight or UV sources.
Citations
Have you cited DEIASL345M in a publication? Let us know and earn a reward for your research.
| Product Name | Cat. No. | Applications | Host Species | Datasheet | Price | Add to Basket |
|---|
| Product Name | Cat. No. | Applications | Host Species | Datasheet | Price | Add to Basket |
|---|
Ye, GJ; Scotti, MM; et al. Herpes Simplex Virus Clearance During Purification of a Recombinant Adeno-Associated Virus Serotype 1 Vector. HUMAN GENE THERAPY CLINICAL DEVELOPMENT 25:212-217(2014).
1. Issa S.S., et al. Various AAV Serotypes and Their Applications in Gene Therapy: An Overview. Cells. 2023;12:785.
2. Ling, Q., et al. AAV-based in vivo gene therapy for neurological disorders. Nat Rev Drug Discov 22. 2023, 789–806.
2. Ling, Q., et al. AAV-based in vivo gene therapy for neurological disorders. Nat Rev Drug Discov 22. 2023, 789–806.
Online Inquiry
Catalog # DEIASL345M
Related Products
By targets
Related Resources
Ordering Information
Payment methods we support:
Invoice / Purchase Order
Credit card
Invoice / Purchase Order
Credit card
